Cerence (CRNC)
(Real Time Quote from BATS)
$9.65 USD
-0.40 (-3.98%)
Updated Apr 25, 2024 09:54 AM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Income Statements
Fiscal Year end for Cerence Inc falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 294 | 328 | 387 | 330 | 303 |
Cost Of Goods | 95 | 97 | 101 | 108 | 99 |
Gross Profit | 199 | 231 | 286 | 222 | 204 |
Selling & Adminstrative & Depr. & Amort Expenses | 227 | 415 | 226 | 202 | 193 |
Income After Depreciation & Amortization | -27 | -184 | 61 | 19 | 11 |
Non-Operating Income | 6 | 0 | 2 | -23 | 0 |
Interest Expense | 15 | 14 | 14 | 23 | 0 |
Pretax Income | -36 | -199 | 48 | -26 | 11 |
Income Taxes | 20 | 112 | 2 | -6 | -89 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -56 | -311 | 46 | -21 | 100 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -56 | -311 | 46 | -21 | 100 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -11 | 53 | 90 | 49 | 40 |
Depreciation & Amortization (Cash Flow) | 16 | 238 | 30 | 30 | 29 |
Income After Depreciation & Amortization | -27 | -184 | 61 | 19 | 11 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 40.22 | 39.19 | 39.29 | 36.43 | 36.39 |
Diluted EPS Before Non-Recurring Items | -0.65 | 0.63 | 1.41 | -0.57 | 2.76 |
Diluted Net EPS (GAAP) | -1.40 | -7.93 | 1.17 | -0.57 | 2.76 |
Fiscal Year end for Cerence Inc falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 138.34 | 80.76 | 61.66 | 68.39 |
Cost Of Goods | NA | 26.34 | 23.03 | 20.94 | 25.01 |
Gross Profit | NA | 112.00 | 57.74 | 40.72 | 43.38 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 53.43 | 53.84 | 49.22 | 63.99 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 58.57 | 3.90 | -8.50 | -20.61 |
Non-Operating Income | NA | 2.85 | -0.42 | -0.82 | 2.24 |
Interest Expense | NA | 3.24 | 3.13 | 4.12 | 4.00 |
Pretax Income | NA | 58.20 | 0.35 | -13.44 | -22.38 |
Income Taxes | NA | 34.34 | 11.90 | 3.01 | 3.71 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 23.86 | -11.55 | -16.46 | -26.09 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 23.86 | -11.55 | -16.46 | -26.09 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.26 | 40.36 | 40.32 | 40.22 |
Diluted EPS Before Non-Recurring Items | NA | 0.95 | -0.13 | -0.22 | -0.35 |
Diluted Net EPS (GAAP) | NA | 0.53 | -0.29 | -0.41 | -0.65 |